Leadership

PFMD has from inception been formed as an equal collaboration among its members which includes patient groups, patients, the pharmaceutical industry and regulators. The leadership and governance model adopted by PFMD ensures at least equal or greater share of voice for patient groups. PFMD activities are funded and supported by member organisations.

Advisory Committee

Nicola Bedlington
Secretary General, European Patients Forum
Veronica Todaro
Vice President, National Programs, Parkinson’s Disease Foundation
Graeme Johnston
Patient Advocate, Individual/ Patient
Stephen Yates
Clinical Program Director, UCB
Roslyn Schneider
Global Patient Affairs Lead, Pfizer
Andrew Benzie
Andrew Benzie

GSK

Paul Robinson
Paul Robinson

Executive Director, Scientific Medical & Patient Perspective, MSD

Guy Yeoman
Guy Yeoman

VP Patient Centricity, AstraZeneca

Rebecca Vermeulen
Rebecca Vermeulen

Head Global Medical Liaisons and Communications, Roche

Mathieu Boudes
Mathieu Boudes

Operations and Project Manager, EURORDIS

Kimberly McCleary
Kimberly McCleary

Managing Director, FasterCures

Lode Dewulf
Lode Dewulf

Consultant, Permanent Guest

Sarah Krüg
Sarah Krüg

Executive Director, CANCER 101

Management Group

Marc Boutin
Marc Boutin

Chief Executive Officer, National Health Council

 Jan Geissler
Jan Geissler

Director, EUPATI

Tony Hoos
Tony Hoos

Head of Medical, Europe, AMGEN

Core Team

The day-to-day activities of PFMD are agreed by members and the Management Team and are delivered in collaboration with The Synergist. 

 Nicholas Brooke
Nicholas Brooke

Executive Director

Helena Harnik
Helena Harnik

Operational Director

Chi Pakarinen
Chi Pakarinen

Project Manager

 Roxana Radu
Roxana Radu

Communication Coordinator

 Anne-Marie Hamoir
Anne-Marie Hamoir

Head of Membership and project management

 Bernadette Hendrickx
Bernadette Hendrickx

Scientific Advisor

Ify Sargeant
Ify Sargeant

Editor in Chief

Geoffroy Ryckaert
Geoffroy Ryckaert

Head of IT